Mezigdomide

N/A

Report date: 2026/02/13 20:01:31
NME

Base Information

Drug NameMezigdomide
Drug Alias NameCC-92480
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionDNA-binding protein Ikaros degradersZinc finger protein Aiolos degraders
TargetsDNA-binding protein IkarosZinc finger protein Aiolos
Therapy Area/IndicationsRenal InsufficiencyHepatic InsufficiencyMultiple Myeloma +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[38] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb SrlcompanyBristol-Myers Squibb (China) Investment Co LtdRoswell Park Cancer Institute +[9] 
Inactive CompaniesN/A
Active IndicationsRenal InsufficiencyHepatic InsufficiencyMultiple Myeloma +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A